Terms: = Gastric cancer AND PALB2, ENSG00000083093, 79728
24 results:
1. Profiling of the genetic features of patients with breast, ovarian, colorectal and extracolonic cancers: Association to CHEK2 and palb2 germline mutations.
Infante M; Arranz-Ledo M; Lastra E; Olaverri A; Ferreira R; Orozco M; Hernández L; Martínez N; Durán M
Clin Chim Acta; 2024 Jan; 552():117695. PubMed ID: 38061684
[TBL] [Abstract] [Full Text] [Related]
2.
Usui Y; Taniyama Y; Endo M; Koyanagi YN; Kasugai Y; Oze I; Ito H; Imoto I; Tanaka T; Tajika M; Niwa Y; Iwasaki Y; Aoi T; Hakozaki N; Takata S; Suzuki K; Terao C; Hatakeyama M; Hirata M; Sugano K; Yoshida T; Kamatani Y; Nakagawa H; Matsuda K; Murakami Y; Spurdle AB; Matsuo K; Momozawa Y
N Engl J Med; 2023 Mar; 388(13):1181-1190. PubMed ID: 36988593
[TBL] [Abstract] [Full Text] [Related]
3. Study on TFF1 and palb2 gene variants associated with gastric carcinoma risk in the Chinese Han population.
Zou W; Zhang Q; Sun R; Li X; He S
Cancer Epidemiol; 2023 Apr; 83():102333. PubMed ID: 36758349
[TBL] [Abstract] [Full Text] [Related]
4. Profiling of the genetic features of Chinese patients with gastric cancer with HRD germline mutations in a large-scale retrospective study.
Zhang C; Zhu D; Qu Y; Shi M; Ma J; Peng Y; Zhu B; Tao H; Ma T; Hou T
J Med Genet; 2023 Aug; 60(8):760-768. PubMed ID: 36627197
[TBL] [Abstract] [Full Text] [Related]
5. Whole-Exome Sequencing Among Chinese Patients With Hereditary Diffuse gastric cancer.
Liu ZX; Zhang XL; Zhao Q; Chen Y; Sheng H; He CY; Sun YT; Lai MY; Wu MQ; Zuo ZX; Wang W; Zhou ZW; Wang FH; Li YH; Xu RH; Qiu MZ
JAMA Netw Open; 2022 Dec; 5(12):e2245836. PubMed ID: 36484990
[TBL] [Abstract] [Full Text] [Related]
6. Hereditary breast cancer: syndromes, tumour pathology and molecular testing.
Sokolova A; Johnstone KJ; McCart Reed AE; Simpson PT; Lakhani SR
Histopathology; 2023 Jan; 82(1):70-82. PubMed ID: 36468211
[TBL] [Abstract] [Full Text] [Related]
7. cancer genetics and breast cancer.
Huber-Keener KJ
Best Pract Res Clin Obstet Gynaecol; 2022 Jun; 82():3-11. PubMed ID: 35272929
[TBL] [Abstract] [Full Text] [Related]
8. Germline cancer Testing in Unselected Patients with gastric and Esophageal cancers: A Multi-center Prospective Study.
Uson PLS; Kunze KL; Golafshar MA; Botrus G; Riegert-Johnson D; Boardman L; Borad MJ; Ahn D; Sonbol MB; Kahn A; Klint M; Esplin ED; Nussbaum RL; Stewart AK; Bekaii-Saab T; Samadder NJ
Dig Dis Sci; 2022 Nov; 67(11):5107-5115. PubMed ID: 35122589
[TBL] [Abstract] [Full Text] [Related]
9. New Perspectives on the Recurrent Monoallelic Germline Mutations of DNA Repair and Checkpoint Genes and Clinical Variability.
Sahin I; Saat H
Genet Test Mol Biomarkers; 2022 Jan; 26(1):17-25. PubMed ID: 35089076
[No Abstract] [Full Text] [Related]
10. gastric cancer genetic predisposition and clinical presentations: Established heritable causes and potential candidate genes.
Garcia-Pelaez J; Barbosa-Matos R; São José C; Sousa S; Gullo I; Hoogerbrugge N; Carneiro F; Oliveira C
Eur J Med Genet; 2022 Jan; 65(1):104401. PubMed ID: 34871783
[TBL] [Abstract] [Full Text] [Related]
11. Germline Pathogenic Variants in cancer Predisposition Genes Among Women With Invasive Lobular Carcinoma of the Breast.
Yadav S; Hu C; Nathanson KL; Weitzel JN; Goldgar DE; Kraft P; Gnanaolivu RD; Na J; Huang H; Boddicker NJ; Larson N; Gao C; Yao S; Weinberg C; Vachon CM; Trentham-Dietz A; Taylor JA; Sandler DR; Patel A; Palmer JR; Olson JE; Neuhausen S; Martinez E; Lindstrom S; Lacey JV; Kurian AW; John EM; Haiman C; Bernstein L; Auer PW; Anton-Culver H; Ambrosone CB; Karam R; Chao E; Yussuf A; Pesaran T; Dolinsky JS; Hart SN; LaDuca H; Polley EC; Domchek SM; Couch FJ
J Clin Oncol; 2021 Dec; 39(35):3918-3926. PubMed ID: 34672684
[TBL] [Abstract] [Full Text] [Related]
12. Disease spectrum of gastric cancer susceptibility genes.
McKinley SK; Singh P; Yin K; Wang J; Zhou J; Bao Y; Wu M; Pathak K; Mullen JT; Braun D; Hughes KS
Med Oncol; 2021 Mar; 38(5):46. PubMed ID: 33760988
[TBL] [Abstract] [Full Text] [Related]
13. Investigation on the Role of palb2 Gene in CDH1-Negative Patients With Hereditary Diffuse gastric cancer.
Carreño M; Pena-Couso L; Mercadillo F; Perea J; Urioste M
Clin Transl Gastroenterol; 2020 Dec; 11(12):e00280. PubMed ID: 33512806
[TBL] [Abstract] [Full Text] [Related]
14. Atypical choroidal nevus in a subject with a germline palb2 pathogenic variant.
Grosel TW; Karl M; Pilarski RT; Davidorf FH; Abdel-Rahman MH; Cebulla CM
Fam Cancer; 2022 Jan; 21(1):1-5. PubMed ID: 33403473
[TBL] [Abstract] [Full Text] [Related]
15. palb2 c.2257C>T truncating variant is a Greek founder and is associated with high breast cancer risk.
Vagena A; Papamentzelopoulou M; Kalfakakou D; Kollia P; Papadimitriou C; Psyrri A; Apostolou P; Fountzilas G; Konstantopoulou I; Yannoukakos D; Fostira F
J Hum Genet; 2019 Aug; 64(8):767-773. PubMed ID: 31089269
[TBL] [Abstract] [Full Text] [Related]
16. Analysis of DNA Damage Response Gene Alterations and Tumor Mutational Burden Across 17,486 Tubular Gastrointestinal Carcinomas: Implications for Therapy.
Parikh AR; He Y; Hong TS; Corcoran RB; Clark JW; Ryan DP; Zou L; Ting DT; Catenacci DV; Chao J; Fakih M; Klempner SJ; Ross JS; Frampton GM; Miller VA; Ali SM; Schrock AB
Oncologist; 2019 Oct; 24(10):1340-1347. PubMed ID: 31040255
[TBL] [Abstract] [Full Text] [Related]
17. Resolving gastric cancer aetiology: an update in genetic predisposition.
Lott PC; Carvajal-Carmona LG
Lancet Gastroenterol Hepatol; 2018 Dec; 3(12):874-883. PubMed ID: 30507471
[TBL] [Abstract] [Full Text] [Related]
18. Germline pathogenic variants in palb2 and other cancer-predisposing genes in families with hereditary diffuse gastric cancer without CDH1 mutation: a whole-exome sequencing study.
Fewings E; Larionov A; Redman J; Goldgraben MA; Scarth J; Richardson S; Brewer C; Davidson R; Ellis I; Evans DG; Halliday D; Izatt L; Marks P; McConnell V; Verbist L; Mayes R; Clark GR; Hadfield J; Chin SF; Teixeira MR; Giger OT; Hardwick R; di Pietro M; O'Donovan M; Pharoah P; Caldas C; Fitzgerald RC; Tischkowitz M
Lancet Gastroenterol Hepatol; 2018 Jul; 3(7):489-498. PubMed ID: 29706558
[TBL] [Abstract] [Full Text] [Related]
19. Pathogenic Germline Variants in 10,389 Adult cancers.
Huang KL; Mashl RJ; Wu Y; Ritter DI; Wang J; Oh C; Paczkowska M; Reynolds S; Wyczalkowski MA; Oak N; Scott AD; Krassowski M; Cherniack AD; Houlahan KE; Jayasinghe R; Wang LB; Zhou DC; Liu D; Cao S; Kim YW; Koire A; McMichael JF; Hucthagowder V; Kim TB; Hahn A; Wang C; McLellan MD; Al-Mulla F; Johnson KJ; ; Lichtarge O; Boutros PC; Raphael B; Lazar AJ; Zhang W; Wendl MC; Govindan R; Jain S; Wheeler D; Kulkarni S; Dipersio JF; Reimand J; Meric-Bernstam F; Chen K; Shmulevich I; Plon SE; Chen F; Ding L
Cell; 2018 Apr; 173(2):355-370.e14. PubMed ID: 29625052
[TBL] [Abstract] [Full Text] [Related]
20. Germline Mutations in palb2, BRCA1, and RAD51C, Which Regulate DNA Recombination Repair, in Patients With gastric cancer.
Sahasrabudhe R; Lott P; Bohorquez M; Toal T; Estrada AP; Suarez JJ; Brea-Fernández A; Cameselle-Teijeiro J; Pinto C; Ramos I; Mantilla A; Prieto R; Corvalan A; Norero E; Alvarez C; Tapia T; Carvallo P; Gonzalez LM; Cock-Rada A; Solano A; Neffa F; Della Valle A; Yau C; Soares G; Borowsky A; Hu N; He LJ; Han XY; ; Taylor PR; Goldstein AM; Torres J; Echeverry M; Ruiz-Ponte C; Teixeira MR; Carvajal-Carmona LG
Gastroenterology; 2017 Apr; 152(5):983-986.e6. PubMed ID: 28024868
[TBL] [Abstract] [Full Text] [Related]
[Next]
